Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 337 results for "sun pharmaceutical industries"

Thomson Reuters Analysis Identifies Hi-Tech Engineering and Ph...

The Intellectual Property & Science business of T homson Reuters , the world's leading source of intelligent information for businesses and professionals, announced the launch of its 2014 State of Innovation India report today. This is the second ... Bobsguide, 1 day ago

17 images for sun pharmaceutical industries

Sify, 1 week ago
Reuters, 1 week ago
Reuters, 2 weeks ago
Money Today, 1 week ago
Reuters India, 1 month ago
Sify, 1 week ago
Sify, 2 weeks ago
Bloomberg, 2 weeks ago
Money Today, 1 month ago
Sify, 1 month ago
Business Standard India

Pharma shares under pressure; CNX Pharma index down nearly 4%

Wockhardt, Glenmark, Torrent Pharma,Aurobindo Pharma, Lupin, Strides Arcolab and Biocon were down 5-9%. SI Reporter | Mumbai December 17, 2014 Last Updated at 10:25 IST Shares of pharmaceutical companies are under pressure, falling by up to 9% on ...
 Business Standard India1 day ago US court overturns Ranbaxy's bid to block launch of rival generic drugs  Business Standard India4 weeks ago U.S. Court Overturns Bid, Setback For Ranbaxy  Indolink3 weeks ago Ranbaxy Fails To Block Launch Of Rival Generic Drugs  Businessworld India4 weeks ago

Pharma exporters slump; EM currency rout hurts

Reuters Market Eye - Pharmaceutical stocks slump - Glenmark Pharmaceutical (GLEN.NS) falls 6 pct, Aurobindo Pharma (ARBN.NS) slumps 6.8 pct, Lupin (LUPN.NS) loses 5.3 pct. Ranbaxy Laboratories (RANB.NS) down 4 pct, Cipla (CIPL.NS) loses 3.6 pct, Sun ...
 Yahoo! Finance1 day ago Lupin, Glenmark Pharma Slump; EM Currency Rout Hurts  NDTV Profit1 day ago
Financial Express

Deal clincher: Sun hoists its flag on domestic pharma landscape

With the Competition Commission of India (CCI) giving conditional approval to Sun Pharmaceutical Industries proposed acquisition of Ranbaxy Laboratories, the stage is set for Sun Pharma to become the largest pharmaceutical company in India, that too ...
 Financial Express3 days ago Sun hoists its flag on domestic pharma landscape  4 Traders2 days ago Sun Pharma leads the gainers list on BSE's Sensex  Arihant Capital6 days ago CCI riders small price for Ranbaxy deal  DNA India1 week ago
Business Line

Pharmaceutical Newsletter - December 08 to 12, 2014

Top News CCI approves proposed merger between Sun Pharma and Ranbaxy The Competition Commission of India (Commission) in its meeting approved the proposed merger between Sun Pharma and Ranbaxy, subject to the parties inter alia carrying out the ...
 India Infoline6 days ago Sun Pharma and Ranbaxy Lab will be in focus after CCI approves merger  Business Standard1 week ago CCI Approves the Proposed Merger Between Sun Pharma and Ranbaxy Subject to Modification  Noodls1 week ago Ministry of Corporate Affairs of Republic of I : CCI Approves the Proposed Merger Between Sun Pharma and Ranbaxy Subject to Modification  4 Traders1 week ago

Pharma companies should be ready to adapt to changing norms: Makov

MUMBAI: Changing regulatory environment will be the norm in the pharmaceutical industry in the days ahead and companies should be ready to adapt, said Israel Makov, chairman of Sun Pharmaceutical, India's biggest and the world's fifth largest drug ...
 Economic Times3 days ago
Business Standard India

CCI rider on brand sell-off to have low impact on Sun Pharma-Ranbaxy

Antitrust regulator Competition Commission of India (CCI) on Monday gave conditional approval to Sun Pharmaceutical Industries to buy Ranbaxy Laboratories. The condition laid down by CCI is that the companies will have to divest seven products to ...
 Business Standard India1 week ago CCI rider likely to have insignificant impact on Sun Pharma-Ranbaxy  Business Standard India1 week ago

Sun-Ranbaxy merger gets conditional nod

The Competition Commission of India has approved the Sun Pharma-Ranbaxy merger with some caveats. According to the conditions imposed by the Commission, the merged entity will have to divest seven drug formulations in which its combined market ...
 Hindu Business Line1 week ago Sun-Ranbaxy Merger Deal Gets Conditional Nod From CCI  Outlook India1 week ago RANBAXY LABORATORIES : Sun-ranbaxy merger gets conditional nod  4 Traders1 week ago

Sun Pharma, Ranbaxy shares surge after CCI approval

Sun Pharmaceutical Industries stock gained 1.4 per cent, while shares of Ranbaxy Laboratories were up over 3 per cent on Tuesday after the Competition Commission of India (CCI) approved Sun Pharma's US $3.2 billion bid to buy Ranbaxy. Shares of ...
 Business Today India1 week ago Sun Pharma, Ranbaxy stocks gain on FIPB nod  Economic Times2 weeks ago Sun Pharma, Ranbaxy gain on FIPB nod  Yahoo! Maktoob News2 weeks ago Sun Pharma Ranbaxy gain after FIPB nod for merger  Capital Market2 weeks ago

Sun Pharma chairman calls for more Indo-Israel collaboration

uch opportunities across the world so that India can tap the knowledge the country has to offer and Israel can look at opportunities here, Sun Pharmaceuticals chairman Israel Makov has said. "India and Israel need to find a way to create more meeting places ...
 Business Standard6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharmaceutical industries
Get updated on latest news & your favorite topics right in your inbox!
More     Less